Clinical trials
Not yet recruiting Phase 1/2 Prostatic Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2025 | 2 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| CHU de Quebec-Universite Laval | 1 |
| CoRegen, Inc. | 1 |
| Mansoura University | 1 |
| Martin Huellner | 1 |
| Mochida Medical USA, Inc. | 1 |
| Qilu Pharmaceutical Co., Ltd. | 1 |
| RadAlliance Therapeutics, Inc | 1 |
| RayzeBio, Inc. | 1 |
| Regeneron Pharmaceuticals | 1 |
| Shenzhen Geno-Immune Medical Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms | 13 |
| Neoplasms | 3 |
| Carcinoma, Hepatocellular | 2 |
| Adenocarcinoma | 1 |
| Anus Neoplasms | 1 |
| Breast Neoplasms | 1 |
| Carcinoma, Transitional Cell | 1 |
| Colorectal Neoplasms | 1 |
| Disease | 1 |
| Endometriosis | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.